175 related articles for article (PubMed ID: 28360204)
1. Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
Vercellino L; Ouvrier MJ; Barré E; Cassinat B; de Beco V; Dosquet C; Chevret S; Meignin V; Chomienne C; Toubert ME; Merlet P; Kiladjian JJ
J Nucl Med; 2017 Oct; 58(10):1603-1608. PubMed ID: 28360204
[TBL] [Abstract][Full Text] [Related]
2. Assessing Bone Marrow Activity with [
Yassin MA; Nehmeh SA; Nashwan AJ; Kohla SA; Mohamed SF; Ismail OM; Al Sabbagh A; Soliman DS; Szabados L; Fayad H
Technol Cancer Res Treat; 2022; 21():15330338221086396. PubMed ID: 35341409
[No Abstract] [Full Text] [Related]
3. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment.
Agool A; Schot BW; Jager PL; Vellenga E
J Nucl Med; 2006 Oct; 47(10):1592-8. PubMed ID: 17015893
[TBL] [Abstract][Full Text] [Related]
4. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ
J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108
[TBL] [Abstract][Full Text] [Related]
5. 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.
Blanchet EM; Taieb D; Millo C; Martucci V; Chen CC; Merino M; Herscovitch P; Pacak K
J Nucl Med; 2015 Dec; 56(12):1849-54. PubMed ID: 26359261
[TBL] [Abstract][Full Text] [Related]
6. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study.
Agool A; Slart RH; Thorp KK; Glaudemans AW; Cobben DC; Been LB; Burlage FR; Elsinga PH; Dierckx RA; Vellenga E; Holter JL
Nucl Med Commun; 2011 Jan; 32(1):17-22. PubMed ID: 21166089
[TBL] [Abstract][Full Text] [Related]
7.
Tsujikawa T; Tasaki T; Hosono N; Mori T; Makino A; Kiyono Y; Zanotti-Fregonara P; Yamauchi T; Okazawa H
EJNMMI Res; 2019 Feb; 9(1):16. PubMed ID: 30771115
[TBL] [Abstract][Full Text] [Related]
8. Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Yue J; Chen L; Cabrera AR; Sun X; Zhao S; Zheng F; Han A; Zheng J; Teng X; Ma L; Ma Y; Han D; Zhao X; Mu D; Yu J; Li Y
J Nucl Med; 2010 Apr; 51(4):528-34. PubMed ID: 20237030
[TBL] [Abstract][Full Text] [Related]
9. F-18 FLT PET: a noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: a pilot study.
Agool A; Slart RH; Kluin PM; de Wolf JT; Dierckx RA; Vellenga E
Clin Nucl Med; 2011 Apr; 36(4):286-9. PubMed ID: 21368602
[TBL] [Abstract][Full Text] [Related]
10. Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Herrmann K; Ott K; Buck AK; Lordick F; Wilhelm D; Souvatzoglou M; Becker K; Schuster T; Wester HJ; Siewert JR; Schwaiger M; Krause BJ
J Nucl Med; 2007 Dec; 48(12):1945-50. PubMed ID: 18006614
[TBL] [Abstract][Full Text] [Related]
11. Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study.
Derlin T; Alchalby H; Bannas P; Veldhoen S; Apostolova I; Triviai I; Bengel FM; Kröger N
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):696-705. PubMed ID: 25601337
[TBL] [Abstract][Full Text] [Related]
12. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
[TBL] [Abstract][Full Text] [Related]
13. Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.
McGuire SM; Bhatia SK; Sun W; Jacobson GM; Menda Y; Ponto LL; Smith BJ; Gross BA; Bayouth JE; Sunderland JJ; Graham MM; Buatti JM
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):228-39. PubMed ID: 27319286
[TBL] [Abstract][Full Text] [Related]
14. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Wondergem MJ; Rizvi SN; Jauw Y; Hoekstra OS; Hoetjes N; van de Ven PM; Boellaard R; Chamuleau ME; Cillessen SA; Regelink JC; Zweegman S; Zijlstra JM
J Nucl Med; 2015 Feb; 56(2):216-21. PubMed ID: 25593118
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
17. Baseline and longitudinal variability of normal tissue uptake values of [
Cysouw MCF; Kramer GM; Frings V; De Langen AJ; Wondergem MJ; Kenny LM; Aboagye EO; Kobe C; Wolf J; Hoekstra OS; Boellaard R
Nucl Med Biol; 2017 Aug; 51():18-24. PubMed ID: 28528264
[TBL] [Abstract][Full Text] [Related]
18. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
19. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
